about
Review of novel therapeutic targets for improving heart failure treatment based on experimental and clinical studies2013 Korean Society of Hypertension guidelines for the management of hypertension. Part II-treatments of hypertensionThe metabolic vascular syndrome - guide to an individualized treatmentEarly Treatment with Basal Insulin Glargine in People with Type 2 Diabetes: Lessons from ORIGIN and Other Cardiovascular TrialsSomatic mosaicism: implications for disease and transmission geneticsCardiac AAV9-S100A1 gene therapy rescues post-ischemic heart failure in a preclinical large animal modelPrevalence of heart failure and atrial fibrillation in minority ethnic subjects: the Ethnic-Echocardiographic Heart of England Screening Study (E-ECHOES)Computational models reduce complexity and accelerate insight into cardiac signaling networksThe regenerative capacity of zebrafish reverses cardiac failure caused by genetic cardiomyocyte depletion.Cardiac myosin activation: a potential therapeutic approach for systolic heart failure.Could vitamin D supplements be a new therapy for heart failure? Possible pathogenic mechanisms from data of intervention studies.Clinical relevance of slow ventricular tachycardia in heart failure patients with primary prophylactic implantable cardioverter defibrillator indication.Principal component analysis of HPLC retention data and molecular modeling structural parameters of cardiovascular system drugs in view of their pharmacological activity.Omecamtiv Mecarbil, a Cardiac Myosin Activator, Increases Ca2+ Sensitivity in Myofilaments With a Dilated Cardiomyopathy Mutant Tropomyosin E54K.Severe postpartum sepsis with prolonged myocardial dysfunction: a case report.Sorting out where fibroblasts come from.Diabetes and CVD risk during angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker treatment in hypertension: a study of 15,990 patients.Resistance training improves hemodynamic function, collagen deposition and inflammatory profiles: experimental model of heart failure.2-Deoxy adenosine triphosphate improves contraction in human end-stage heart failure.Cyclic AMP is both a pro-apoptotic and anti-apoptotic second messenger"Second-generation" stem cells for cardiac repairEndomyocardial implantation of autologous bone marrow mononuclear cells in advanced ischemic heart failure: a randomized placebo-controlled trial (END-HF).Potassium and risk of Type 2 diabetesAn overview of candesartan in clinical practice.Use and Limitations of E/e' to Assess Left Ventricular Filling Pressure by EchocardiographyOne-year Mortality after an Acute Coronary Event and its Clinical Predictors: The ERICO Study.Extracellular RNAs: development as biomarkers of human disease.Roles of microRNA-34a targeting SIRT1 in mesenchymal stem cells.Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart functionEarly echocardiographic predictors of increased left ventricular end-diastolic pressure three months after myocardial infarction in rats.It's Time for An Epigenomics Roadmap of Heart FailureChronic Heart Failure Clinical Practice Guidelines' Class 1-A Pharmacologic Recommendations: Start-to-End Synergistic Drug Therapy?Aldosterone deficiency prevents high-fat-feeding-induced hyperglycaemia and adipocyte dysfunction in miceClinical effects of Xinmailong therapy in patients with chronic heart failure.AAV6-mediated Cardiac-specific Overexpression of Ribonucleotide Reductase Enhances Myocardial Contractility.Generalized Multiscale Entropy Analysis: Application to Quantifying the Complex Volatility of Human Heartbeat Time Series.Role of imaging in the detection of reversible cardiomyopathy.Antihypertensive efficacy of the angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril.The 12-lead ECG in peripartum cardiomyopathyBMP Antagonist Gremlin 2 Limits Inflammation After Myocardial Infarction.
P2860
Q26746907-85B9C10A-566D-4CA9-9372-3DBF916BE9DCQ26764784-10FDB4DF-B23F-4A2A-AC78-6D97F9DD09AEQ26767142-F6F8AD50-EE35-4D03-86B9-3E8F7E2593C1Q26767164-BFF107FE-98B0-4D17-AF63-F38D862C0CB7Q27016060-E60BF677-B738-4604-BC97-F9812926301AQ28243737-7F08EC37-C151-4BB0-A62E-CE7174347BA1Q28742689-928AFF90-0854-4D8B-AF81-49B8AB5CDB25Q30428985-C5DA2DF4-BF37-4AED-B336-A01BAA2CD8E9Q30502828-17673391-1C58-498B-82F8-E29D203400CFQ30583292-0F5F7A31-9C1C-435A-A00E-34ED6FE4C37FQ30831509-28EEA4C3-D8EF-4C57-9D04-1C97FF4C3E37Q33162261-FCFBFEE6-C174-4C98-8DA9-B21FEED4C485Q33662066-A7480F8A-FDF9-4760-AA57-E8830C8BB6AAQ33768442-42C505A8-6DF2-442B-A75B-758F7A77449EQ34221236-15650005-6F13-4C20-9F60-77C81B43ACB9Q34251249-BB8C00D8-7FE1-4405-A9C7-FAD32FAD5258Q34312115-6B509626-2AB9-4F74-98D9-D9D393DB344FQ34395152-6B98B7F4-D5B9-4DFF-B378-E9CB55411669Q34995668-BAA2B1FB-E810-45B7-AB7C-192686BB497DQ35074567-219EAFBA-539E-49EE-BE5E-7EA2EBA9AE99Q35205665-E5180AED-E630-4A4C-B47E-97094CA51B73Q35216415-F32B478E-AEB0-44F1-AABA-762D3BC9939AQ35400567-2A2191F1-9670-4502-9F90-D0BC7A18D80EQ35453845-0360F78A-BEB1-44CE-8885-13985D2C3B3BQ35676084-31A44B4D-EDB7-4D40-A294-2DE7DCF7C502Q35911633-D9600D67-94D4-4270-B91F-8C90DF61A8C2Q36006446-0BF1A9F7-C3E4-4F43-A33C-E63967BE33EEQ36135052-F119F18E-C7D4-4157-9FCB-E49DAB05E9B6Q36378477-88FD2D6C-180D-48AF-9836-26A1626A3DF1Q36577551-9105EA81-EEFE-418C-AEA0-026C8D5382AFQ36613033-CA68BF70-AEEA-4596-9521-9F2BACA47CA0Q36661094-1CE1670F-350D-4471-8068-B786B21993DAQ36672857-EE63AF22-7563-4488-9426-AC9D18BA71A4Q36746865-8E173538-6B0C-4C8B-BD3E-006783BEC67CQ36756838-C741F649-3CC9-476F-BC39-FE4F130FB8D1Q36807802-1B632CA2-20AE-459A-B87E-FC996F1AC5DFQ36983228-3ABAF7EF-F754-4C39-BA36-51B7E134DBFFQ37025604-7ADFCD9B-3A9D-40F0-A7F9-E4598988D269Q37073321-717597A0-CB11-4C83-8171-26F42007C225Q37127457-1CDB221F-24B1-4841-A30A-0D2AFDF00747
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Clinical practice. Systolic heart failure.
@ast
Clinical practice. Systolic heart failure.
@en
Clinical practice. Systolic heart failure.
@nl
type
label
Clinical practice. Systolic heart failure.
@ast
Clinical practice. Systolic heart failure.
@en
Clinical practice. Systolic heart failure.
@nl
prefLabel
Clinical practice. Systolic heart failure.
@ast
Clinical practice. Systolic heart failure.
@en
Clinical practice. Systolic heart failure.
@nl
P356
P1476
Clinical practice. Systolic heart failure
@en
P2093
John J V McMurray
P304
P356
10.1056/NEJMCP0909392
P407
P577
2010-01-01T00:00:00Z